Polygenic Score for beta-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart Failure

David E. Lanfear*, Jasmine A. Luzum, Ruicong She, Hongsheng Gui, Mark P. Donahue, Christopher M. O'Connor, Kirkwood F. Adams, Sandra Sanders-van Wijk, Nicole Zeld, Micha T. Maeder, Hani N. Sabbah, William E. Kraus, Hans-Peter Brunner-La Rocca, Jia Li, L. Keoki Williams

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number007012
Number of pages12
JournalCirculation-Heart Failure
Volume13
Issue number12
DOIs
Publication statusPublished - Dec 2020

Keywords

  • atrial fibrillation
  • pharmacogenetics
  • population groups
  • precision medicine
  • 2013 ACCF/AHA GUIDELINE
  • ASSOCIATION TASK-FORCE
  • RISK SCORE
  • ADRENERGIC-RECEPTOR
  • ATRIAL-FIBRILLATION
  • AMERICAN-COLLEGE
  • PROPENSITY SCORE
  • GENETIC RISK
  • VARIANTS
  • COMMON

Cite this